Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy

Background: Among patients with non-small cell lung cancer (NSCLC), we compared the progression-free survival (PFS) and proportion of acquisition of T790M mutation of the epidermal growth receptor gene (EGFR) after first-line treatment with epidermal growth factor receptor-tyrosine kinase inhibitors...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diagnostics (Basel)
Auteurs principaux: Inomata, Minehiko, Azechi, Kenji, Takata, Naoki, Hayashi, Kana, Tokui, Kotaro, Taka, Chihiro, Okazawa, Seisuke, Kambara, Kenta, Imanishi, Shingo, Miwa, Toshiro, Hayashi, Ryuji, Matsui, Shoko, Tobe, Kazuyuki
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7759886/
https://ncbi.nlm.nih.gov/pubmed/33255696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10121006
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires